Putnam Associates at a Glance


  • "The firm culture, which is shaped by a small environment filled with young, smart, and motivated individuals."
  • "Firm culture, rapid promotional opportunity."
  • "The great colleagues and the interesting case work."
  • "High level of responsibility, great people, great exit opportunities."


  • "The ungodly cold!"
  • "The unpredictable hours."
  • "The occasional expectation that one be always available regardless of time or place."
  • "Lack of robust formal training for experienced hires."

The Buzz

  • "Academic"
  • "Limited opportunities for growth."
  • "Healthcare."
  • "New leadership growing fast."

About Putnam Associates


Life Sciences specialists

For over 25 years, Putnam Associates has developed its niche as a premier strategy consulting firm serving pharmaceutical, biotechnology, diagnostics, medical device, and related clients in the healthcare space. The firm provides objective, high impact strategic advice and analytical services, helping to support clients in crucial business decisions at all stages of the product and franchise lifecycle.In the past five years alone, the firm's roughly 60 professionals have completed more than 600 projects. Putnam has served many of its core clients for more than a decade, while continuing to add new clients, major drivers of recent and future growth.


Product placement

Given its exclusive focus on life sciences, most of Putnam's services focus on maximizing clients' investment in new and existing products. That's good news for the firm's clients, who can spend more than 10 years developing new products-including wading through discovery, comprehensive testing, regulatory reviews, and market research-before the products are launched.

Putnam works with clients to develop strategies based on rigorous issue framing and data-driven analyses, often combining academic literature (epidemiological, clinical), third-party data (claims data, prescribing data), financial reporting data, and primary research conducted through Putnam's extensive global network of physicians, managed care organizations, hospitals, pharmacies, wholesalers and government representatives. Services in this segment include market opportunity evaluations, competitive landscape assessments, product development strategies, in-licensing assessments, product positioning and marketing, launch and growth strategies, pricing and contracting strategies, sales force effectiveness and product lifecycle planning. Putnam works with all of the top-10 global biopharmaceutical companies, several leading mid-tier biopharmaceutical companies, as well as venture-backed biotechs, medical device, and diagnostic companies. Despite being based in the US, approximately half of Putnam's projects in 2013 were global in focus.


Committed to long-term relationships

By providing clients with both insight and long-term support, Putnam has become the strategic partner of choice to a growing roster of clients-with many individual relationships stretching back a decade or more. That long-term commitment also goes for the firm's employees; rather than being a landing spot for a year or two, the firm wants employees to see the potential for a longer-term career at Putnam. Accordingly, the firm is dedicated to providing both formal and informal mentorship, and supports an enriching professional culture, all in the name of fostering a collegial environment. Specific initiatives include an internal weekly seminar series to keep teams connected with one another, with advances in project methodology and new developments in health care. Mentorship, training, and tuition reimbursement programs encourage employees to continue learning. In addition, Putnamites can be found at annual national medical conferences in oncology, transplantation and other therapeutic areas, ensuring that the firm stays on the cutting edge of the latest industry trends. Putnam maintains a prominent thought-leadership profile in the industry by creating focused knowledge development presentations that can be shared with selected clients, and by sharing insights more broadly via white papers, guest lectures, and conference panel participation. 

The firm's commitment to junior employee development is evidenced by its outstanding track-record in getting these employees into top-tier MBA programs. It has achieved 100% placement success in recent years, and in the past two years alone the firm has sent multiple employees to programs at Harvard/HBS, MIT/Sloan, UPenn/Wharton and Stanford/GSB. Additionally, several recent MBA graduates have elected to take advantage of the firm's recently expanded sponsorship program and return to Putnam as Senior Consultants. Further evidence of that long-term commitment to employees can be found in the fact that more than half of the Partners and Principals at the firm started at Putnam as entry-level employees. 


Ensuring a successful launch

Nearly half of Putnam's projects in the past year have dealt with the challenge of bringing cutting edge medical innovations to market. Often an asset in development has multiple potential indications (e.g., treatment of particular types of immune disorders or different types of cancers). In one recent project, Putnam helped validate the epidemiology of untreated patient populations, then worked with the client to better define the real unmet medical needs in the therapeutic area, leading to recommendations around pivotal Phase III trial designs. Putnam then worked with the commercial team to build strategies around introducing the product to target markets, pricing the product, and attaining reimbursement. At the same time, Putnam helped build forecast models for key countries, and conducted pipeline assessments to help the client keep apace of fast moving clinical developments among competitors and to consider potential complementary in-licensing opportunities (complementary products for different subpopulations, or for combination therapies). 

The field of life sciences is exceptionally complex and fast paced. Whether Putnam's clients are evaluating their portfolios, developing new products, trying to grow marketed products, or trying to optimize late life-cycle products, the firm's strength lies in its ability to consistently deliver exceptional work and superior insights on the industry's complex challenges.



June 2014

Putnam Moving Headquarters to Boston

With recent growth, Putnam announced it will be moving its headquarters in early 2015 to a larger office in the heart of Boston, near Copley Square. The new space, located on Boylston Street, will double the size of the current office and include state of the art technology, work stations, and meeting space.


February 2014

Putnam Sponsors Xconomy's Meet the Xconomists Networking Evening

Putnam sponsored Xconomy's networking event "Meet the Xconomists" bringing together world-class leaders in life sciences, technology, business, and investing who are fueling future innovation and growth. Learn more here.


November 2013

Putnam Sponsors Harvard Medical School's Healthcare Innovation & Commercialization Day

Healthcare Innovation & Commercialization (HIC) is a Harvard Medical School non-credit course created with the goal of helping MDs, PhDs and Post-docs to succeed in life sciences entrepreneurship and medical innovation. 

One of the course highlights is the Innovation Fair. This event brings together a wide range of current technologies from Harvard in a "science fair" type format. Experienced entrepreneurs, innovators and HMS students discuss the potential of presented ideas. The firm was proud to sponsor and support Harvard Medical School in this program. Joseph Feingold, Manager at Putnam, served as a mentor throughout the course and Domenick Bertelli, Partner at Putnam, joined him as a judge at the Innovation Fair. Read more here.


October 2013

New Senior Leadership Team Announced

The firm announced the appointment of a new senior leadership team, naming Eric Auger to chair the Partnership Committee and Remco op den Kelder to head of the Boston Office. Both Eric and Remco have been at Putnam for over a decade and have served in various leadership positions, playing an important role in both practice and internal development since the early 2000s. 

In addition, Putnam named John Gordon as Chief Financial Officer, Domenick Bertelli as Chief Marketing Officer, and Paul Bogorad and Matthew Riordan to co-chair the firm's Talent Committee. Read more here.

- Show Less + Show Full Description

Putnam Associates

501 Boylston Street
Boston, MA 02116
Phone: (617) 456-5200
Fax: (781) 273-5484


  • Employer Type: Private
  • Partner, Boston Office Head: Remco op den Kelder
  • 2014 Employees: 65

  • Employment Contact
    Visit Putnam's careers page

  • Major Departments & Practices
    Corporate Strategy Established Product Strategy New Products Strategy Portfolio, Licensing & Development Strategy Pricing, Reimbursement, & Market Access

Major Office Locations

  • Burlington, MA (HQ)

Become a Vault Basic Member

Complete your Vault Profile and get seen by top employers